Ultra-Low Dose of Rituximab Safely Eases Rheumatoid Arthritis Over Long Term: Study
TUESDAY, Nov. 9, 2021 (HealthDay News) — “Ultra-low” doses of the drug rituximab may be enough to keep some patients’ rheumatoid arthritis under control for several years, a new, preliminary study suggests. Researchers found that among 118 patients, low doses of the drug were comparable to standard ones in controllingContinue Reading